BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/22/2024 4:25:08 AM | Browse: 424 | Download: 1292
Publication Name World Journal of Stem Cells
Manuscript ID 89874
Country Italy
ISSN 1948-0210 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Biology
Manuscript Type Editorial
Article Title Use of priming strategies to advance the clinical application of mesenchymal stromal/stem cell-based therapy
Manuscript Source Invited Manuscript
All Author List Vitale Miceli
ORCID
Author(s) ORCID Number
Vitale Miceli http://orcid.org/0000-0001-8922-9909
Funding Agency and Grant Number
Corresponding Author Vitale Miceli, PhD, Academic Editor, Research Scientist, Department of Research, Istituto Mediterraneo per i Trapianti e Terapie ad alta Specializzazione, Via Tricomi 5, Palermo 90127, Italy. vmiceli@ismett.edu
Key Words Mesenchymal stromal/stem cells; Therapeutic properties; Paracrine effects; Cell priming; Cell-free therapies; Regenerative medicine
Core Tip Mesenchymal stromal/stem cells (MSCs) offer important therapeutic effects in the field of regenerative medicine. Their key role lies in the production of paracrine factors that modulate tissue environments and allow their repair following insults. Recently, MSC-derived products such as exosomes and conditioned media are replacing whole MSCs in clinical applications. In this regard, to optimize the results of MSC-based treatment, researchers have explored priming strategies in order to enhance MSC properties. Realizing the full potential of MSC therapy depends on identifying the right tissue source and developing priming strategies specific to the disease being treated.
Publish Date 2024-01-22 04:25
Citation Miceli V. Use of priming strategies to advance the clinical application of mesenchymal stromal/stem cell-based therapy. World J Stem Cells 2024; 16(1): 7-18
URL https://www.wjgnet.com/1948-0210/full/v16/i1/7.htm
DOI https://dx.doi.org/10.4252/wjsc.v16.i1.7
Full Article (PDF) WJSC-16-7-with-cover.pdf
Full Article (Word) WJSC-16-7.docx